A common diabetes drug can reduce the pain of people with knee osteoarthritis and overweight or obesity, possibly delaying ...

A common diabetes drug can reduce the pain of people with knee osteoarthritis and overweight or obesity, possibly delaying the need for knee replacements, Monash University-led research has found.

The diabetes drug metformin provided overweight/obese patients with osteoarthritis (OA) of the knee with significantly ...

For patients undergoing THA, OA severity is the best predictor of preoperative biomechanical function, and preoperative muscle fat fraction is the best predictor of postoperative function.